Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
癌症相关的CD15/FUT4过表达会降低靶向EGFR或VEGF药物的疗效,其在转移性结直肠癌中发挥着新型RAF-MEK-ERK激酶下游调节因子的作用。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-015-0225-7
Giordano, Guido; Febbraro, Antonio; Tomaselli, Eugenio; Sarnicola, Maria Lucia; Parcesepe, Pietro; Parente, Domenico; Forte, Nicola; Fabozzi, Alessio; Remo, Andrea; Bonetti, Andrea; Manfrin, Erminia; Ghasemi, Somayehsadat; Ceccarelli, Michele; Cerulo, Luigi; Bazzoni, Flavia; Pancione, Massimo
肿瘤
肠癌
肿瘤免疫
信号转导
EGF
MAPK/ERK
CD15
EGFR
VEGF